Discover Financial Servi... DFS - Catena di Opzioni | ADVFN

Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Registrati

Home
Investire
Azioni
U.S.A.
NYSE
Discover Financial Services (DFS)
Discover Financial Services (DFS) Opzioni

Discover Financial Services (DFS)

158,62

-12,23

(-7,16%)

Chiuso 11 Aprile 10:00PM

Ritardato di 15 minuti

156,93

-1,69

( -1,07% )

Pre Mercato: 11:04AM

Ritardato di 15 minuti

DFS Flusso Di Opzioni

Call

Strike	Denaro	Lettera	Ultimo Prezzo	Punto Medio	Var	Var %	Volume	INT APERTO	Ora Ultimo Ordine
143,00	14,10	18,20	0,00	16,15	0,00	0,00 %	0	0	-
144,00	13,30	17,50	11,80	15,40	0,00	0,00 %	0	6	-
145,00	12,40	16,50	8,65	14,45	0,00	0,00 %	0	1	-
146,00	11,50	16,00	12,00	13,75	0,00	0,00 %	0	4	-
147,00	10,80	15,00	11,30	12,90	0,00	0,00 %	0	3	-
148,00	9,90	13,20	14,00	11,55	0,00	0,00 %	0	5	-
149,00	9,10	13,00	9,00	11,05	0,00	0,00 %	0	4	-
150,00	8,30	12,00	13,45	10,15	0,00	0,00 %	0	28	-
152,50	6,20	10,00	10,48	8,10	8,48	424,00 %	1	10	10/4/2025
155,00	4,50	6,90	7,27	5,70	4,93	210,68 %	18	43	10/4/2025
157,50	2,85	5,20	5,50	4,025	-10,00	-64,52 %	3	59	10/4/2025
160,00	1,85	3,90	3,00	2,875	-6,10	-67,03 %	11	18	10/4/2025
162,50	0,70	3,60	2,00	2,15	0,00	0,00 %	0	56	-
165,00	0,05	2,00	2,00	1,025	-6,30	-75,90 %	1	33	10/4/2025
167,50	0,05	2,50	1,42	1,275	-3,97	-73,65 %	1	85	10/4/2025
170,00	0,20	2,35	2,10	1,275	-3,60	-63,16 %	1	81	10/4/2025
172,50	0,05	2,10	1,12	1,075	-2,48	-68,89 %	2	34	10/4/2025
175,00	0,20	2,15	2,50	1,175	0,00	0,00 %	0	64	-
177,50	0,05	2,15	0,05	1,10	0,00	0,00 %	0	11	-
180,00	0,35	0,55	0,60	0,45	0,25	71,43 %	1	38	10/4/2025

Discussioni in tempo reale e idee di trading: Fai trading con fiducia con la nostra potente piattaforma.

Put

Strike	Denaro	Lettera	Ultimo Prezzo	Punto Medio	Var	Var %	Volume	INT APERTO	Ora Ultimo Ordine
143,00	0,05	1,80	9,05	0,925	0,00	0,00 %	0	2	-
144,00	0,10	2,60	7,30	1,35	0,00	0,00 %	0	1	-
145,00	0,40	1,55	0,78	0,975	-0,67	-46,21 %	1	185	10/4/2025
146,00	0,15	2,80	2,25	1,475	0,00	0,00 %	0	2	-
147,00	0,25	2,20	2,60	1,225	0,00	0,00 %	0	2	-
148,00	0,30	1,90	1,00	1,10	-1,89	-65,40 %	30	2	10/4/2025
149,00	0,40	1,90	9,55	1,15	0,00	0,00 %	0	0	-
150,00	0,90	2,75	1,20	1,825	-0,15	-11,11 %	1	22	10/4/2025
152,50	0,75	3,30	5,12	2,025	0,00	0,00 %	0	4	-
155,00	1,35	4,00	2,20	2,675	0,60	37,50 %	11	42	10/4/2025
157,50	2,55	5,10	3,22	3,825	1,07	49,77 %	1	22	10/4/2025
160,00	2,35	5,80	4,68	4,075	1,93	70,18 %	6	52	10/4/2025
162,50	4,30	7,10	3,97	5,70	-12,63	-76,08 %	1	28	10/4/2025
165,00	6,40	9,50	18,67	7,95	0,00	0,00 %	0	13	-
167,50	6,60	11,30	21,40	8,95	-0,00	0,00 %	0	15	-
170,00	10,40	13,90	11,37	12,15	5,52	94,36 %	1	14	10/4/2025
172,50	12,60	15,70	22,70	14,15	0,00	0,00 %	0	3	-
175,00	15,10	18,40	26,73	16,75	0,00	0,00 %	0	32	-
177,50	18,40	20,90	0,00	19,65	0,00	0,00 %	0	0	-
180,00	20,10	23,10	27,00	21,60	0,00	0,00 %	0	10	-

Più Attivi
% Guadagnanti
% Perdenti

Simbolo	Prezzo	Vol.
MSPRMSP Recovery Inc	US$ 2,85 (122,66%)	9,67M
STSSSharps Technology Inc	US$ 0,0317 (73,22%)	96,06M
ELDNEledon Pharmaceuticals Inc	US$ 4,52 (59,72%)	30
TURN180 Degree Capital Corporation	US$ 5,71 (56,87%)	2
AIPArteris Inc	US$ 8,99 (48,84%)	3
EFSIEagle Financial Services Inc	US$ 11,01 (-63,72%)	17
ALTIAITi Global Inc	US$ 1,20 (-57,30%)	204
FNWBFirst Northwest Bancorp	US$ 5,00 (-50,20%)	114
SRBKSR Bancorp Inc	US$ 7,00 (-42,10%)	251
PHLTPerformant Healthcare Inc	US$ 1,50 (-38,02%)	205
STSSSharps Technology Inc	US$ 0,0317 (73,22%)	96,06M
LGMKLogicMark Inc	US$ 0,0098 (4,26%)	74,09M
DMNDamon Inc	US$ 0,0035 (-16,67%)	47,16M
MSPRMSP Recovery Inc	US$ 2,85 (122,66%)	9,67M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 8,14 (-3,67%)	7,96M

BADALI

BADALI 2 minuti fa

More shares are coming to the markets now

n4807g

n4807g 5 minuti fa

All good points. Every investor needs to evaluate risk and hopefully understand their financial requirements at every stage in life. I'd hope that retirees would have a balanced portfolio (with a cash component) that would reduce risk and take into account current market conditions, and the potent

The Danish Dude

The Danish Dude 6 minuti fa

Having researched this, I believe it is not worth "having on our radar".

🔍 Patent WO2025/072823 and the AdHER2 Dendritic Cell Vaccine: A Consolidated Assessment
📘 What the Patent Covers
WO2025/072823, filed by the U.S. Department of Health and Human Servi

Drugdoctor

Drugdoctor 7 minuti fa

Just INCREDIBLE - $STSS .032 up 66% on 100 million shares VOLUME in the early premarket!

getmenews

getmenews 11 minuti fa

Note; when my customers start cancelling orders, WATCH OUT BELOW!

Nice day

Its_TradingG

Its_TradingG 11 minuti fa

You're waking up!

Its_TradingG

Its_TradingG 12 minuti fa

Lmao RGBP IS DOWN 90% in the last year!!! Cmon man

jeunke22

jeunke22 20 minuti fa

Could you or whoever maybe imagine that sometimes you can actually learn something when having a conversation ?
Put it differently, can you imagine that ‘failure’ isn’t always the opposite of success—it’s a stepping stone toward it? I know these are just words, but I do believe in the force

ChangnoiPlaza

ChangnoiPlaza 20 minuti fa

Something about WAMU – Summary:

In the LIBOR case, there were about 20 companies involved in the fraud.

If, in the WAMU case, the key decision-makers (like JPMorgan or the FDIC) were attempting fraud, they would have to deceive not just a handful—but 6,800 companies.

Bob Mullet

Bob Mullet 23 minuti fa

Yet whatever you say
Whenever you say it
Whatever' you think
Every Friday is
Another week another webs burger post....

Dyno89

Dyno89 25 minuti fa

RGBP was / is another typical otc scam the last I followed anything on it. Don't remember any meaningful "major" partnership or anything else that benefited shareholders there. Followed that one while I was in ENZC. Must be just like ENZC's "Samsung bio" partnership that literally was a nothing burg

ChangnoiPlaza

ChangnoiPlaza 29 minuti fa

Something about WAMU Part II: In 2012, there was the vote on the POR7, and there was also a document listing the companies/individuals who voted on it. The document can be found here:
https://www.veritaglobal.net/document/0812229120326000000000003

Now that it's 2025 – and Chat

Drugdoctor

Drugdoctor 30 minuti fa

$STSS up 70% to .03 in-premarket-on-80-MILLION-shares-VOLUME!

getmenews

getmenews 34 minuti fa

I will add at the market open 4/11/2025

Nice day

nwsun

nwsun 39 minuti fa

Based on your history of posting you don't have a great track record of picking winners. More like losers

ChangnoiPlaza

ChangnoiPlaza 40 minuti fa

Somthing about wamu PART I

I would like to draw attention to the absolute numbers of equity holders as well as the number of companies that agreed to the POR7 in 2012.

First, the document from 2008:
Notice of Filing of List of Equity Holders
https://www.

diggitydoodle

diggitydoodle 42 minuti fa

It's Friday again, and the end of another week of nothing new.
Silence from the great CEO continues. Progress for this ticker is non existent. And, the pumpers prove that they know nothing.
Maybe the week ends with something from the great CEO. We'll see.
GLTA!
RNVA!!$$??

Krombacher

Krombacher 42 minuti fa

StrategyOne,

ssc’s mockery aside, your question is exactly the right one to be asking. It’s not rhetorical—it’s directional. And you’re right: a functioning market depends on transparency, accessibility, and participation.

But markets are also shaped by perception. And

bigfart

bigfart 45 minuti fa

US markets has lost 5 trillion dollars in 3 weeks

buysellrepeat

buysellrepeat 51 minuti fa

Why would I report anything to the SEC? That doesn't make sense. I'm saying be careful. My opinion is I see something I'm not comfortable with. What a foolish escalation on your part.

Bull_Dolphin

Bull_Dolphin 54 minuti fa

Go Dead Eye! Wouldn't this be a great swap?

https://www.thegatewaypundit.com/2025/04/texas-ag-ken-paxton-announces-senate-run-against/

0210

0210 55 minuti fa

TGIF, Zardiw! are we hvn’ fun o wut? 😆

🫣guessing here, DD Amanda on DMN in-the-works, sooner than later, lol. 👍🥂🥱😴🤑🤫

DocLee

DocLee 59 minuti fa

Interesting short interview this morning on BBC Radio4 with the Deputy Director of the MHRA concerning a https://www.gov.uk/government/news/first-ever-mhra-analysis-of-uk-clinical-trial-applications-finds-new-opportunities-to-drive-medical-breakthroughs-for-patients review by the MHRA (click here)

FanOfspringsteen

FanOfspringsteen 1 ora fa

At least... You should also mention that "The Betas in Europe" .... Have social protection you are far from having, and just for that, i'm glad to be a beta. . In fact.. This sad situation will affect every one in the world and Us people first.

Discover Financial Servi...

African Pioneer

LENZ Therapeutics

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni